Literature DB >> 21627770

[S3-guidelines for the treatment of psoriasis vulgaris Update 2011].

Alexander Nast1, Wolf-Henning Boehncke, Ulrich Mrowietz, Hans-Michael Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Adel Sammain, Martin Schlaeger, Michael Sebastian, Wolfram Sterry, Volker Streit, Matthias Augustin, Ricardo Erdmann, Joachim Klaus, Joachim Koza, Siegrid Müller, Hans-Dieter Orzechowski, Stefanie Rosumeck, Gerhard Schmid-Ott, Tobias Weberschock, Berthold Rzany.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21627770     DOI： 10.1111/j.1610-0379.2011.07680.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  21 in total

Review 1.  [Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

Authors:  F Behrens; D Thaçi; J Wollenhaupt; K Krüger
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

Review 2.  Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis.

Authors:  Alexander Nast; Anja Jacobs; Stefanie Rosumeck; Ricardo N Werner
Journal:  J Invest Dermatol       Date:  2015-06-05       Impact factor: 8.551

3.  [CD30-positive anaplastic large cell T-cell lymphoma developing during immunosuppressive therapy of pityriasis rubra pilaris with ustekinumab].

Authors:  D Humme; M Beyer; H-J Röwert-Huber; W Sterry; S Philipp
Journal:  Hautarzt       Date:  2013-03       Impact factor: 0.751

Review 4.  [Differential diagnostic spectrum of psoriasis vs. psoriatic arthritis in skin and joints].

Authors:  S Gerdes; U Mrowietz; U Wagner
Journal:  Z Rheumatol       Date:  2017-08       Impact factor: 1.372

Review 5.  [Children and adolescents with psoriasis. What therapy is recommended?].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

Review 6.  [Retinoids in dermatopharmacology].

Authors:  P M Amann; H F Merk; J M Baron
Journal:  Hautarzt       Date:  2014-02       Impact factor: 0.751

Review 7.  [Inverse psoriasis].

Authors:  P Weisenseel; K Reich
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

8.  [Methotrexate-associated photosensitization].

Authors:  K Hoffmann; F Casetti; C Schempp
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

Review 9.  [Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

Authors:  F Behrens; D Thaçi; J Wollenhaupt; K Krüger
Journal:  Z Rheumatol       Date:  2016-06       Impact factor: 1.372

10.  Fixed Combination Aerosol Foam Calcipotriene 0.005% (Cal) Plus Betamethasone Dipropionate 0.064% (BD) is More Efficacious than Cal or BD Aerosol Foam Alone for Psoriasis Vulgaris: A Randomized, Double-blind, Multicenter, Three-arm, Phase 2 Study.

Authors:  Mark Lebwohl; Stephen Tyring; Michael Bukhalo; Javier Alonso-Llamazares; Martin Olesen; David Lowson; Paul Yamauchi
Journal:  J Clin Aesthet Dermatol       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.